Trial · NCT04033003
Outcomes20
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Ability to Identify Danger Signs in Pregnancy | T0 Baseline (at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery) | Group ANC: Number of participants analyzed at T0 = 877; Number of participants analyzed at T1 = 617 Standard ANC: Number of participants analyzed at T0 = 884; Number of participants analyzed at T1 = 668 | units on a scale | MEAN |
| PRIMARY | Change in Birth Preparedness and Complication Readiness | T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery) | Group ANC: Number of participants analyzed at T0 = 877; Number of participants analyzed at T1 = 617 Standard ANC: Number of participants analyzed at T0 = 884; Number of participants analyzed at T1 = 668 | units on a scale | MEAN |
| PRIMARY | Change in Ability to Identify Newborn Danger Signs | T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery) | Group ANC: Number of participants analyzed at T0 = 877; Number of participants analyzed at T1 = 617 Standard ANC: Number of participants analyzed at T0 = 884; Number of participants analyzed at T1 = 668 | units on a scale | MEAN |
| PRIMARY | Attendance of ANC Visits | T2 (6-12 weeks after delivery) | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Place of Delivery | T2 (6-12 weeks after delivery) | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Attendance at Postpartum Check-ups for Mother | T2 (6-12 weeks after delivery) | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Attendance at Postnatal Check-up for Newborn | T2 (6-12 weeks after delivery) | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Birth Outcome | T2 (6-12 weeks after delivery) | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Change in Health Literacy | T0 (Baseline at recruitment) and T2 (6 - 12 weeks postdelivery) | Group ANC: Number of participants analyzed at T0 = 877; Number of participants analyzed at T2 = 585 Standard ANC: Number of participants analyzed at T0 = 884; Number of participants analyzed at T2 = 596 | score on a scale | MEAN |
| SECONDARY | Change in Ability to Identify Postpartum Danger Signs for Mother | T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery) | Group ANC: Number of participants analyzed at T0 = 877; Number of participants analyzed at T1 = 617 Standard ANC: Number of participants analyzed at T0 = 884; Number of participants analyzed at T1 = 668 | units on a scale | MEAN |
| SECONDARY | Change in Ability to Identify the Recommended Action Steps When a Problem is Identified | T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery) | Group ANC: Number of participants analyzed at T0 = 877; Number of participants analyzed at T1 = 617 Standard ANC: Number of participants analyzed at T0 = 884; Number of participants analyzed at T1 = 668 | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Change in Knowledge of Family Planning Methods | T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery) | Group ANC: Number of participants analyzed at T0 = 877; Number of participants analyzed at T1 = 617 Standard ANC: Number of participants analyzed at T0 = 884; Number of participants analyzed at T1 = 668 | units on a scale | MEAN |
| SECONDARY | Change in Intent to Use Family Planning | T0 (Baseline at recruitment) and T1 (34 weeks gestation - 3 weeks postdelivery) | Group ANC: Number of participants analyzed at T0 = 747; Number of participants analyzed at T1 = 526 Standard ANC: Number of participants analyzed at T0 = 760; Number of participants analyzed at T1 = 525 | units on a scale | MEAN |
| SECONDARY | Change in Uptake of Family Planning | T2 (6-12 weeks after delivery), T3 (5 - 8 months postpartum), and T4 (11 - 14 months postpartum) | Group ANC: Number of participants analyzed at T2 = 585; Number analyzed at T3 = 619; Number analyzed at T4 = 609 Standard ANC: Number of participants analyzed at T0 592= ; Number analyzed at T1 = 673; Number analyzed at T4 = 674 Participants lost to follow-up at T2 and T3 remain eligible to complete surveys at subsequent timepoints. Thus, there may be more participants analyzed at later timepoints. | units on a scale | MEAN |
| SECONDARY | Change in Interpersonal Violence | T0 (baseline) and T4 (11 - 14 months postpartum) | Group ANC: Number of participants analyzed at T0 = 873 ; Number of participants analyzed at T4 = 626 Standard ANC: Number of participants analyzed at T0 = 884; Number of participants analyzed at T4 = 686 | units on a scale | MEAN |
| SECONDARY | Experience of ANC Care | T2 (6-12 postpartum) | units on a scale | MEAN | |
| SECONDARY | Completion of IPTp2 Malaria Prophylaxis During Pregnancy | T1 (34 weeks gestation - 3 weeks postdelivery) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Completion of Least Two Tetanus Toxoid Vaccines During Pregnancy | T1 (34 weeks gestation - 3 weeks postdelivery) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Newborn Weight | T2 (6-12 weeks postpartum) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Mother's Hemoglobin at Delivery in Grams Per Deciliter (g/dl). | T2 (6 - 12 weeks postpartum) | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04033003/outcomes